Leptin as an adjunct of insulin therapy in insulin-deficient diabetes - PubMed (original) (raw)
. 2003 Oct;46(10):1329-37.
doi: 10.1007/s00125-003-1193-6. Epub 2003 Aug 20.
Affiliations
- PMID: 12928770
- DOI: 10.1007/s00125-003-1193-6
Leptin as an adjunct of insulin therapy in insulin-deficient diabetes
F Miyanaga et al. Diabetologia. 2003 Oct.
Abstract
Aims/hypothesis: The purpose of this study was to assess the therapeutic implication of leptin in insulin-deficient diabetes.
Methods: Insulin-deficient diabetes was induced by streptozotocin (STZ) in transgenic skinny mice overexpressing leptin. Plasma concentrations of glucose, insulin, and leptin were measured. The effects on body weight, food intake, and hypothalamic gene expressions were analyzed. After diabetes was induced, graded doses of insulin ranging from 0.4 to 51.2 mU.g(-1).day(-1) were injected. Co-administration of leptin and insulin was also carried out using osmotic pumps.
Results: After STZ injection, both transgenic and non-transgenic littermates developed marked hyperglycaemia as a result of severe hypoinsulinaemia [termed diabetic transgenic skinny mice overexpressing leptin (diabetic TGM) and diabetic non-transgenic littermates (diabetic WT) respectively], although diabetic TGM were more sensitive to exogenously administered insulin than diabetic WT. Diabetic WT were hypoleptinaemic and hyperphagic relative to non-diabetic WT, whereas diabetic TGM, which remained hyperleptinaemic, were less hyperphagic than diabetic WT. After STZ injection, hypothalamic expressions of orexigenic and anorexigenic peptide mRNAs were up-regulated and down-regulated, respectively, in diabetic WT, whereas they were unchanged in diabetic TGM. Diabetic TGM became normoglycaemic, when treated with insulin at such doses that did not improve hyperglycaemia in diabetic WT. We found that a sub-threshold dose of insulin that does not affect glucose homeostasis is effective in improving the diabetes in normal mice rendered diabetic by STZ injection, when combined with leptin.
Conclusions/interpretation: This study suggests that leptin could be used as an adjunct of insulin therapy in insulin-deficient diabetes, thereby providing an insight into the therapeutic implication of leptin as an anti-diabetic agent.
Similar articles
- Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin.
Mizuno TM, Makimura H, Silverstein J, Roberts JL, Lopingco T, Mobbs CV. Mizuno TM, et al. Endocrinology. 1999 Oct;140(10):4551-7. doi: 10.1210/endo.140.10.6966. Endocrinology. 1999. PMID: 10499510 - Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice.
Sindelar DK, Mystkowski P, Marsh DJ, Palmiter RD, Schwartz MW. Sindelar DK, et al. Diabetes. 2002 Mar;51(3):778-83. doi: 10.2337/diabetes.51.3.778. Diabetes. 2002. PMID: 11872679 - Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats.
Hidaka S, Yoshimatsu H, Kondou S, Oka K, Tsuruta Y, Sakino H, Itateyama E, Noguchi H, Himeno K, Okamoto K, Teshima Y, Okeda T, Sakata T. Hidaka S, et al. J Neurochem. 2001 May;77(4):993-1000. doi: 10.1046/j.1471-4159.2001.00317.x. J Neurochem. 2001. PMID: 11359864 - The role of leptin in the regulation of carbohydrate metabolism.
Tucholski K, Otto-Buczkowska E. Tucholski K, et al. Endokrynol Pol. 2011;62(3):258-62. Endokrynol Pol. 2011. PMID: 21717410 Review. - Hypothalamic-mediated control of glucose balance in the presence and absence of insulin.
Fujikawa T, Coppari R. Fujikawa T, et al. Aging (Albany NY). 2014 Feb;6(2):92-7. doi: 10.18632/aging.100641. Aging (Albany NY). 2014. PMID: 24589844 Free PMC article. Review.
Cited by
- Translational science: Newly emerging science in biology and medicine - Lessons from translational research on the natriuretic peptide family and leptin.
Nakao K. Nakao K. Proc Jpn Acad Ser B Phys Biol Sci. 2019;95(9):538-567. doi: 10.2183/pjab.95.037. Proc Jpn Acad Ser B Phys Biol Sci. 2019. PMID: 31708497 Free PMC article. Review. - Role of Hormone-sensitive Lipase in Leptin-Promoted Fat Loss and Glucose Lowering.
Takanashi M, Taira Y, Okazaki S, Takase S, Kimura T, Li CC, Xu PF, Noda A, Sakata I, Kumagai H, Ikeda Y, Iizuka Y, Yahagi N, Shimano H, Osuga JI, Ishibashi S, Kadowaki T, Okazaki H. Takanashi M, et al. J Atheroscler Thromb. 2017 Nov 1;24(11):1105-1116. doi: 10.5551/jat.39552. Epub 2017 Apr 12. J Atheroscler Thromb. 2017. PMID: 28413180 Free PMC article. - Pleotropic Acute and Chronic Effects of Leptin to Reverse Type 1 Diabetes.
Perry RJ. Perry RJ. Postdoc J. 2017 Jan;5(1):3-11. doi: 10.14304/surya.jpr.v5n1.2. Postdoc J. 2017. PMID: 28239611 Free PMC article. - Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications.
Coleman SK, Rebalka IA, D'Souza DM, Hawke TJ. Coleman SK, et al. World J Diabetes. 2015 Dec 10;6(17):1323-36. doi: 10.4239/wjd.v6.i17.1323. World J Diabetes. 2015. PMID: 26674848 Free PMC article. Review. - Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages.
Tate M, Robinson E, Green BD, McDermott BJ, Grieve DJ. Tate M, et al. Basic Res Cardiol. 2016 Jan;111(1):1. doi: 10.1007/s00395-015-0518-1. Epub 2015 Nov 23. Basic Res Cardiol. 2016. PMID: 26597728 Free PMC article.
References
- Diabetes Care. 1995 Nov;18(11):1415-27 - PubMed
- Metabolism. 1985 Oct;34(10):923-5 - PubMed
- Diabetes. 1999 Jun;48(6):1275-80 - PubMed
- N Engl J Med. 1983 Mar 3;308(9):485-91 - PubMed
- J Clin Endocrinol Metab. 1999 Dec;84(12):4545-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials